On June 1st, TIF representatives, Dr Androulla Eleftheriou and Dr Michael Angastiniotis and Mr Loris Brunetta, Board Member, had a fruitful discussion with patient advocates from the AMRO region about the pandemic’s situation reports and challenges related to individuals with thalassaemia in these areas.
Febbraio 3, 2020
Giugno 19, 2019
COVID-19: TIF Releases Position Statement on the Inclusion of Thalassaemia & SCD Patients in the High-Risk Population
Aprile 21, 2020
Marzo 4, 2019